-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Piclidenoson in Plaque Psoriasis (Psoriasis Vulgaris)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Piclidenoson in Plaque Psoriasis (Psoriasis Vulgaris) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Piclidenoson in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details:Piclidenoson (CF-101) is under...
-
Company Profile
MEKO AB – Company Profile
Meko AB (Meko) is a car spare parts and accessories retailer based in Sweden. It sells tires, wheels, automotive and power tools, car-care products, car accessories, and electronic spare parts. The company markets these products under brands such as Carwise, and ProMeister. Mekonomen also provides automotive-related services such as car insurance, servicing, and repairs. Meko operates retail stores and affiliated workshops under the brands such as MECA, Mekonomen, Marinshopen, Speedy and Bilxtra. It also offers its products through an e-commerce...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – piclidenoson
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry piclidenoson Drug Details Piclidenoson (CF-101) is under development for the treatment of Sjogren's syndrome,...